Saeid Babaei

Biography

Dr. Babaei has over 20 years of experience in leadership roles in the biopharmaceutical industry. He is currently Co-Founder, President, & CEO of AbCelex Technologies, a vaccine developing biotechnology company. Prior to AbCelex, Dr. Babaei has served as Vice President of Business Development at Aptose Biosciences Inc. (formerly known as Lorus Therapeutics Inc.) where he played a key role in a broad range of activities including establishing joint ventures, obtaining private financings, investor relations, and business development.     He successfully negotiated a partnership deal for Virulizin(R), a cancer immunotherapy product candidate to Zor Pharmaceuticals LLC ("ZOR"), a subsidiary of ZoticonBioventures Inc. Previously, Dr. Babaei’s served as Director of Corporate Development at Northern Therapeutics Inc, a biopharmaceutical company which develops novel cell and gene therapies, where he was instrumental in launching the ‘first’ cell-based gene therapy clinical trial for patients with pulmonary arterial hypertension. He played key roles in obtaining financings, and in securing a partnership deal with United Therapeutics. Dr. Babaei’s has served as President of AngioCell providing partnering support and advice to a range of clients on licensing, M&A, pipeline valuation, strategic planning and project financing.

Research Interest

pipeline valuation, strategic planning and project financing